1 | ELAFIBRANOR | [1] Elafibranor Elafibranor | [1] D11208
D11208
(Name: Elafibranor) | [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
2 | Elafibranor 120 mg | [1] Elafibranor Elafibranor | [1] D11208
D11208
(Name: Elafibranor) | [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
3 | Elafibranor 80 mg | [1] Elafibranor Elafibranor | [1] D11208
D11208
(Name: Elafibranor) | [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
4 | Elafibranor 80mg | [1] Elafibranor Elafibranor | [1] D11208
D11208
(Name: Elafibranor) | [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |